FMP
Absci Corporation
ABSI
NASDAQ
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
4.58 USD
-0.135 (-2.95%)
About
ceo
Mr. Sean McClain
sector
Healthcare
industry
Biotechnology
website
https://www.absci.com
exchange
NASDAQ
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
CIK
0001672688
ISIN
US00091E1091
CUSIP
00091E109
Address
18105 SE Mill Plain Boulevard
Phone
360 949 1041
Country
US
Employee
155
IPO Date
Jul 22, 2021
Summary
CIK
0001672688
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
00091E109
ISIN
US00091E1091
Country
US
Price
4.58
Beta
2.37
Volume Avg.
1.58M
Market Cap
515.99M
Shares
-
52-Week
1.111-6.72
DCF
-1.33
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-3.81
P/B
-
Website
https://www.absci.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ABSI News
It looks like there's no news available.
